Global point of care molecular diagnostics market is estimated to grow at a CAGR of 8.2% during the forecast period. The market players which include QuantuMDx Group Ltd., DnaNudge, Aptitude Medical Systems, and others are contributing to the growth of the market by adopting various strategies such as partnership, collaboration, and funding that in turn drive the market growth. For instance,
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/point-of-care-molecular-diagnostics-market
- In November 2022, QuantuMDx Group Ltd., and A.Menarini Diagnostics S.r.I. (Menarini), announced an exclusive distribution agreement for QuantuMDx’s Q-POC platform in the UK and France. Under the terms of the agreement, Menarini market, sell and service Q-POC, QuantuMDx’s SARS- CoV-2 assay and its new SARS-CoV-2, Flu A/B, RSV Respiratory Panel test.
- In March 2022, Minute Molecular Diagnostics announced that the US Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH SARS-CoV-2/S Test. Minute Molecular’s polymerase chain reaction (PCR) test operates on a small instrument called the DASH Analyzer, which consolidates the entire PCR testing process providing a result in approximately 15 minutes.
- In March 2023, DnaNudge, announced a strategic partnership with Mylab Discovery Solutions to develop next-generation molecular diagnostics for diabetic foot infections and other key health conditions. The first delivery from this landmark partnership is an innovative diabetic foot ulcer detection kit to help clinicians rapidly identify bacteria involved in infections and optimally treat patients at the point of decision, reducing the risks of acute complications, limb amputation and antimicrobial resistance (AMR).
- In April 2023, Aptitude Medical Systems announced that it received an award of up to $53.7 million from the Biomedical Advanced Research and Development Authority (BARDA). The funding supports the development of over-the-counter molecular diagnostics capable of delivering lab-quality results in 15-30 minutes while approaching the cost of antigen tests. The funding leveraged advancements achieved by Aptitude’s testing platform, Metrix, through $19.6 million in funding to develop and validate at-home COVID and COVID/Flu tests and up to $34.1 million allocated for options to develop additional multiplex tests for other infectious disease threats.
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered-
o by Application
o By End User
o By Technology
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- including Abott Laboratries, Becton, Dickinson and Co.,Bosch Healthcare Solutions GmbH,Siemens Healthineers, Thermo Fisher Scientific Inc.,Enzo Biochem, Eurofins Scientific, Fluxergy, and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Point of Care Molecular Diagnostics Market Report Segment
By Application
- Influenza
- Mononucleosis
- Respiratory Infectious Disease
- Gastrointestinal Infectious Disease
- Sexually Transmitted Disease
- Others (prenatal testing, and endocrinology)
By End User
- Hospitals
- Homecare
- Others (decentralized labs)
By Technology
- PCR
- Genetic Sequencing
- Hybridization
- Microarray
A full report of Point of Care Molecular Diagnostics Market available @ https://www.omrglobal.com/industry-reports/point-of-care-molecular-diagnostics-market
Global Point of Care Molecular Diagnostics Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Accelerate Diagnostics
- Access Bio
- Ador Diagnostics
- ADT Biotech
- Akonni Biosystems
- Alveo Technologies
- Antelope Dx
- Applied BioCode
- Aureum Diagnostics
- Aus Diagnostics
- Baebies
- Beckman Coulter Diagnostics
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
